ArticleBreast cancer (Tokyo, Japan)2023

Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort.

Laetitia Collet et al.PubMed ↗Publisher ↗

No numbers read from the abstract.